Sanofi's MenQuadfi receives EU approval for infants from six weeks
Evaxion to present three-year cancer vaccine data at ESMO Congress 2026
Evaxion presents new preclinical data on cytomegalovirus vaccine EVX-V1
Northwest Biotherapeutics presents on propensity score matching at BNOS 2026
Taiwan biomedical startups hold over 100 business meetings at BIO 2026
SK bioscience to lead Gates Foundation-funded ROTOR project
Anixa Biosciences' breast cancer vaccine technology granted first Korean patent
Transgene expands myvac platform into non-small cell lung cancer with TG4070
Replicate Bioscience awarded Gates Foundation grant to advance srRNA vaccine candidates for TB
Anixa secures Canadian patent milestone for ovarian cancer vaccine
Transgene to present preclinical TG-MVA mpox vaccine data at World Congress on Infectious Diseases
4basebio secures clinical supply agreement for Phase II immunotherapy trial
GSK's Arexvy gains expanded approval in Japan for at-risk adults aged 18-49
Bavarian Nordic secures USD97m US vaccine contract expansion and raises 2026 outlook